FDA Approves Lymphir for Rare Blood Cancer. The U.S. Food and Drug Administration (FDA) has approved Lymphir, a groundbreaking therapy…
FDA Approves Lymphir for Rare Blood Cancer. The U.S. Food and Drug Administration (FDA) has approved Lymphir, a groundbreaking therapy…